Charles Schwab Investment Management Inc Pliant Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $429 Billion
  • Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 430,286 shares of PLRX stock, worth $4.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
430,286
Previous 424,196 1.44%
Holding current value
$4.56 Million
Previous $7.68 Million 16.55%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$14.14 - $19.59 $86,112 - $119,303
6,090 Added 1.44%
430,286 $6.41 Million
Q4 2023

Feb 06, 2024
BUY
$12.85 - $19.15 $76,971 - $114,708
5,990 Added 1.43%
424,196 $7.68 Million
Q3 2023

Nov 08, 2023
BUY
$14.58 - $20.15 $894,862 - $1.24 Million
61,376 Added 17.2%
418,206 $7.25 Million
Q2 2023

Aug 09, 2023
BUY
$18.12 - $30.56 $2.54 Million - $4.29 Million
140,314 Added 64.81%
356,830 $6.47 Million
Q1 2023

May 11, 2023
BUY
$18.73 - $36.26 $821,497 - $1.59 Million
43,860 Added 25.4%
216,516 $5.76 Million
Q4 2022

Feb 13, 2023
BUY
$17.0 - $25.43 $64,226 - $96,074
3,778 Added 2.24%
172,656 $3.34 Million
Q3 2022

Nov 14, 2022
BUY
$7.67 - $24.23 $554,817 - $1.75 Million
72,336 Added 74.93%
168,878 $3.53 Million
Q2 2022

Aug 15, 2022
SELL
$4.11 - $8.75 $288,665 - $614,556
-70,235 Reduced 42.11%
96,542 $774,000
Q1 2022

May 13, 2022
BUY
$7.01 - $14.1 $33,570 - $67,524
4,789 Added 2.96%
166,777 $1.17 Million
Q4 2021

Feb 11, 2022
BUY
$12.27 - $18.26 $46,957 - $69,881
3,827 Added 2.42%
161,988 $2.19 Million
Q3 2021

Nov 16, 2021
BUY
$16.48 - $28.98 $1.04 Million - $1.83 Million
63,282 Added 66.7%
158,161 $2.67 Million
Q2 2021

Aug 16, 2021
BUY
$28.05 - $37.69 $38,091 - $51,183
1,358 Added 1.45%
94,879 $2.76 Million
Q1 2021

May 17, 2021
BUY
$24.52 - $40.23 $725,203 - $1.19 Million
29,576 Added 46.25%
93,521 $3.68 Million
Q4 2020

Feb 16, 2021
BUY
$19.89 - $32.99 $18,557 - $30,779
933 Added 1.48%
63,945 $1.45 Million
Q3 2020

Nov 13, 2020
BUY
$21.54 - $29.53 $1.36 Million - $1.86 Million
63,012 New
63,012 $1.43 Million

Others Institutions Holding PLRX

# of Institutions
148
Shares Held
63.8M
Call Options Held
417K
Put Options Held
123K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $516M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email